About myFloraScan
Our vision
myFloraScan aims to enhance everyone’s well-being by focusing on digestive health. We recognise that overall health begins with the gut, but understanding the internal processes is crucial. Our aim is to assist our customers through gut microbiome analysis, employing cutting-edge science and technology.
At the same time, we are diligently focusing on utilising the varied diagnostic capabilities of the gut microbiome. This approach will assist in clinical research to assess the importance of the gut microbiome in medical treatments. Moving forward, diagnoses and tailored treatment plans should rely on the unique gut microbiome of each patient. (see BiomeDx)
Place holder
Product Manager
Renate Matzner, BSc
PartnerLead
Business Developer
Place holder
Place holder
Finance Manager
Place holder
Software Developer
Unser Advisory Board
Univ.-Prof.in Dr.in Christine Moissl-Eichinger
Advisor
Univ.-Prof. David Berry, PhD
Advisor
Univ.-Prof. Dipl.-Biol. Dr. Alexander Loy
Advisor
Our reliable
Partner laboratory
We have a long-standing research collaboration with our partner laboratory at the Medical University of Vienna. The Next-Generation DNA Sequencing laboratory method is used for the myBioma gut microbiome analysis. This allows for the determination of the genetic information of each bacterium in a stool sample.
Our ongoing
Research on the microbiome
Research is where innovation really meets discovery! At myFloraScan, it’s crucial for us to always stay at the cutting edge of knowledge. That is why we are actively involved in research projects.
Irritable bowel and microbiome
We investigate the microbial signature of irritable bowel syndrome (IBS) using biofilms. At the same time, we analyse the impact of endoscopic biofilm removal on the restoration of a "healthy" microbiome composition and bile acid metabolism.
Colorectal cancer and microbiome
We define predictive microbiome-based signatures that are specific to colorectal cancer and high-risk adenomas, using multivariate statistical modeling.
Acne and the microbiome
This interventional, double-blind, placebo-controlled clinical trial will investigate the connections between acne/rosacea and the gut microbiome during oral probiotic therapy.
Nutrition recommendations tailored to your gut
